Inflammatory mechanisms underlying potentiation of effects of inhaled aeroallergens in response to nitrogen dioxide in allergic airways disease.
M T
MT
Krishna
S T
ST
Holgate
D000485:Allergens / Q000276:immunology*; D000730:Androstadienes / Q000627:therapeutic use; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D001798:Blood Proteins / Q000378:metabolism*; D004357:Drug Synergism; D047091:Eosinophil Granule Proteins; D004804:Eosinophils / Q000187:drug effects / Q000276:immunology*; D000068298:Fluticasone; D006801:Humans; D017817:Nasal Lavage Fluid; D009297:Nasal Mucosa / Q000187:drug effects; D009299:Nasal Provocation Tests; D009330:Nebulizers and Vaporizers; D009585:Nitrogen Dioxide / Q000494:pharmacology*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy / Q000276:immunology*; D012260:Ribonucleases
D000485:Allergens; D000730:Androstadienes; D018926:Anti-Allergic Agents; D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D000068298:Fluticasone; D012260:Ribonucleases; D009585:Nitrogen Dioxide